Brief: Renovorx Formation Of Renovocath Medical Advisory Board To Support Clinical And Strategic Initiatives
10/02/2026 13:51
Feb 10 (Reuters) - RenovoRx Inc RNXT.O: RENOVORX - FORMATION OF RENOVOCATH MEDICAL ADVISORY BOARD TO SUPPORT CLINICAL AND STRATEGIC INITIATIVES Source text: ID:nGNXbMGl1C Further company coverage: RNXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer